| A, to, T, mutations, |
A/A, genotype, |
| A/C, heterozygote, |
A/C+C/C, genotypes, , |
’’auto’’, inflammatory, disease, |
| ’’gene, activation’’, |
’’oral, Crohn, disease’’, |
’’pseudo-resistance’’, |
| ’’renopoietic, system’’, |
’’shared, epitope’’, SE, |
’essential, ’, MC, |
| ’no, specific, diagnosis’, |
’seed, sequence’, |
A1166C), |
| A1166C, gene, polymorphism, |
A1298C, |
A1c, |
| A1c, criteria, |
A1C, variability, |
A2B, receptors, |
| A555V, and, G809V, |
AA, amyloid, |
AA, amyloidosis, |
| AA, genotype, |
AA, nephropathy, |
AA+VA, genotype, |
| AA-associated, nephropathy, |
AA-DNA, adducts, |
AAT2DM-ESRD, |
| AAV, |
abacavir, |
Abatacept, |
| abberant, signaling, |
ABCA1, |
ABCA1-mediated, cholesterol, efflux, |
| ABCB1, |
ABCC2, |
ABCC2, gene, |
| ABCG2, |
abdominal, adipose, tissue, |
abdominal, aorta, narrowing, |
| abdominal, aortic, aneurysm, |
abdominal, computer, tomography, |
abdominal, pain, |
| abdominal, surgery, |
abdominal, symptoms, |
abelson, nonreceptor, tyrosine, kinase, c-Abl, |
| aberrant, allelels, |
aberrant, CK2, |
aberrant, demethylation, |
| aberrant, DNA, methylation, |
aberrant, global, DNA-methylation, |
aberrant, immune, system, |
| aberrant, MAPK, activation, |
aberrant, O-glycosylation, |
aberrant, sialylation, |
| ablation, procedures, |
abnormal, angiogenesis, |
abnormal, blood, vesses, |
| abnormal, bone, histology, |
abnormal, ciliary, structure, |
abnormal, depositions, |
| abnormal, hemodynamics, |
abnormal, imprinting, patterns, |
abnormal, mineralization, |
| abnormal, regulation, |
abnormal, somatosensory, potential, |
abnormally, glycosylated, IgA1, |
| ABO, incompatibility, |
ABO, incompatible, living, donor, |
ABO, incompatible, living, transplantation, |
| ABO-incompatible, (ABO-I), kidney, transplant, |
ABO-incompatible, (ABO-I), kidney, transplants, |
Aboriginal, and, non-Aboriginal, children, |
| Aboriginal, people, |
abortion, |
ABPM, |
| absence, of, coexisting, disease, |
absence, of, multiple, arteries, |
absence, of, TLR, signaling, |
| absent-or-mild, AoM, |
absorption, |
abstainers, |
| ABT-263, |
ACACB, gene, |
ACAT, 2, |
| ACAT2, |
accelerate, progression, |
accelerate, renal, damage, |
| accelerated, atherosclerosis, |
accelerated, erythropoiesis, |
ACCOMPLISH, trial, |
| ACCORD/ADVANCE/VADT, /UKPDS, |
ACE, |
ACE, /, eNOS, polymorphism, |
| ACE, D, allele, DD, genotype, (ACE, I/D), |
ACE, DD, genotype, |
ACE, expression, |
| ACE, gene, |
ACE, gene, polymorphism, |
ACE, gene, variants, |
| ACE, I/D, gene, polymorphism, |
ACE, I/D, genotype, |
ACE, I/D, polymorphism, |
| ACE, II/ID, genotype, |
ACE, inhbitors, ACEI, |
ACE, inhibition, |
| ACE, inhibitor, |
ACE, inhibitors, ACEI, |
ACE, insertion/deletion, |
| ACE, insertion/deletion, (I/D), genetic, polymorphism, |
ACE, insertion/deletion, ACE, I/D, |
ACE, locus, |
| ACE, mRNA, |
ACE2, |
ACE2, angiotensin, 1-7, |
| ACE2, mRNA, |
ACE2, protein, activity, |
ACE2-angiotensin-(1-7), |
| ACE-activity, |
ACEI, |
ACEI, /ARB, |
| ACEI, /ARBs, |
ACEI/ARB, |
ACEI/ARB, discontinuation, |
| ACEI/ARB, therapy, |
ACEI/NSAIDs/salicylates, |
ACEI/statin, |
| ACE-inhibitor, |
ACE-inhibitors, |
ACEIs, |
| acetaldehyde-protein, adducts, |
acetaminophen, |
acetylcholine, |
| acetylcholine, Ach, |
acetylcholinesterase, enzyme, |
acetyl-CoA, acetyltransferase, 1, |
| acetyl-coenzyme, A, carboxylase, beta, |
acetylsalicylic, acid, |
acetylsalicylic, acid, ASA, |
| acid, phosphatase/ischemic, tissue, lesions, |
acid-base, status, |
acidosis, |
| ACKD2-4, PCKD5D, |
acquired, AAE, |
acquired, angioedema, |
| acquired, deficiencies, |
acquired, disease, s, |
acquired, forms, |
| acquired, hypocomplementemia, |
acquired, immune, deficency, syndrome, AIDS, |
acquired, immune, response, |
| acquired, immunodeficiency, |
acquired, immunodeficiency, syndrome, |
acquired, immunodeficiency, syndrome, AIDS, |
| acquired, lipodystrophy, |
acquired, long, QT, syndrome, |
acquired, long-QT, syndrome, |
| acquired, proteinuric, diseases, |
acquired, reactive, perforating, collagenosis, ARPC, |
acquired, renal, disorders, |
| acquired, thrombophilia, |
acquired, trafficking, defect, of, the, K(+), channel, protein, |
acquired, von, Willebrand, syndrome, AVWS, |
| acquired-/genetic, human, diseases, |
ACR, |
ACR-classified, WG, |
| acrophase, |
ACTH, |
actigraphy, |
| actin, |
actin, cytoskeleton, |
actinin, alpha4, |
| actinomycosis, |
activ, lesions, |
activated, B, cells, |
| activated, complements, |
activated, leukocytes, |
activated, macrophages, |
| activated, mesangial, cells, |
activated, partial, thromboplastin, time, aPTT, |
activated, T, cells, |
| activated, T, lymphocytes, CD4(+), |
activated, transcription, factor, 6, ATF6, |
activating, transcriptional, factor, 2, ATF2, |
| activation, |
activation, markers, |
activation, of, NF-kB, |
| activation, of, transcription, factors, |
activator, protein, 1, AP-1, |
active, (AI)-/chronicity, (CI), indices, |
| active, biosynthetic, healing, |
active, group, |
active, hepatitis, B, or, C, virus, coinfection, |
| active, IgAN, |
active, leflunomide, metabolite, LEF-A, |
active, lesions, |
| active, metabolites, |
active, nephritis, |
active, phase, |
| active, proliferative, glomerulonephritis, |
active, renal, disease, |
active, state, |
| active, vaccination, |
active, vitamin, |
active, vitamin, D, analogues, |
| active, vitamin, D, compounds, |
activities, of, daily, living, ALS, |
activity, index, |
| activity, scores, |
ACTN4, mutations, |
ACTN4/CD1AP/, TRPC6, |
| actomyosin, |
actual, psychologic, distress, |
actual, rate, of, progression, |
| acut, tubular, necrosis, ATN, |
acute, allograft, rejection, |
acute, and, acute-on-chronic, liver, failure, |
| acute, antibody, mediated, rejection, AMR, |
acute, aortic, dissection, |
acute, asthma, |
| acute, cardiac, injury, |
acute, cellular, rejection, |
acute, cellular, rejection, ACR, |
| acute, changes, |
acute, chest, syndrome, |
acute, chest, syndrome, ACS, |
| acute, cholangitis, |
acute, complications, |
acute, coronary, syndrome, |
| acute, coronary, syndrome, ACS, |
acute, crescentic, glomerulonephritis, |
acute, CRS, |
| acute, decompensated, heart, failure, |
acute, decompensated, heart, failure, ADHF, |
acute, decompensated, HF, ADHF, |
| acute, dialysis, |
acute, disease, |
acute, diseases, |
| acute, disseminated, encephalomyelitis, |
acute, distress, syndrome, ARDS, |
acute, enteritis, |
| acute, fatty, liver, |
acute, functional, parenchymal, renal, injury, AFPRI, |
acute, generalized, hives, |
| acute, glomerular, injuries, |
acute, glomerulonephritis, |
acute, glomerulonephritis, AGN, |
| acute, glomerulonephritis, APSGN, |
acute, GN, |
acute, graft, rejection, AR, |
| acute, graft, vasculopathy, |
acute, graft-versus-host, disease, aGVHD, |
acute, heart, failure, AHF, |
| acute, hemorhagic, compli-cations, |
acute, hepatitis, |
acute, hepatitis, A, |
| acute, hepatitis, A, AHA, |
acute, humoral, rejection, |
acute, hydrocephalus, |
| acute, illness, |
acute, injury, |
acute, intermittent, porphyria, AIP, |
| acute, interstitial, nephritis, |
acute, interstitial, nephritis, AIN, |
acute, interstitial, rejection, |
| acute, intestinal, angioedema, |
acute, ischemia, |
acute, ischemic, injury, |
| acute, ischemic, insults, |
acute, ischemic, limb, |
acute, ischemic, stroke, |
| acute, ischemic/reperfusion, injury, |
acute, kidney, disease, |
acute, kidney, disease, AKD, |
| acute, kidney, disease, AKI, |
acute, kidney, failure, AKF, |
acute, kidney, injury, |
| acute, kidney, injury, AKI, |
Acute, Kidney, Injury, Network, AKIN, |
acute, leukocytoclastic, vasculitis, |
| acute, lung, injury, ALI, |
acute, lymphoblastic, leukemia, |
acute, lymphocytic, leukaemia, ALL, |
| acute, lymphocytic, leukemia, |
acute, lymphocytic, leukemia1, |
acute, myeloid, leukemia, |
| acute, myeloid, leukemia, AML, |
acute, myocardial, infarction, AMI, |
acute, nephritic, syndrome, |
| acute, nephritis, |
acute, nephritis, syndrome, |
acute, nephrotoxicity, |
| acute, oliguric, renal, failure, |
acute, oxalate, nephropathy, |
acute, phase, death, |
| acute, phase, protein, |
acute, phase, response, |
acute, phase, response, protein, |
| acute, phosphate, nephropathy, |
acute, phosphate, nephropathy, APhN, |
acute, phosphate, nephropathy, APN, |
| Acute, Physiology, and, Chronic, Health, Evaluation, II, |
acute, porphyris, attacks, |
acute, post, streptococcal, glomerulonephritis, APSGN, |
| acute, postinfectious, glomerulonephritis, |
acute, post-infectious, glomerulonephritis, PIGN, |
acute, post-streptococcal, glomerulonepheitis, APSGN, |
| acute, poststreptococcal, glomerulonephritis, |
acute, post-streptococcal, glomerulonephritis, |
acute, poststreptococcal, glomerulonephritis, APSGN, |
| acute, post-streptococcal, glomerulonephritis, APSGN, |
acute, poststreptococcal, glomerulonephritis, ASPGN, |
acute, posttransplant, complications, |
| acute, proliferative, glomerulonephritis, APGN, |
acute, pulmonary, edema, |
acute, pulmonary, embolism, APE, |
| acute, pyelonephritis, |
acute, rejection, |
acute, rejection, ACR, |
| acute, rejection, AR, |
acute, rejection, episode, |
acute, renal, allograft, dysfunction, |
| acute, renal, allograft, rejection, |
acute, renal, diseases, |
acute, renal, dysfunction, |
| acute, renal, failure, |
acute, renal, failure, AFR, |
acute, renal, failure, ARF, |
| acute, renal, faliure, ARF, |
acute, renal, injury, |
acute, respiratory, distress, syndrome, ARDS, |
| acute, respiratory, illness, |
acute, rhabdomyolysis, |
acute, rheumatic, fever, |
| acute, rheumatic, fever, RF, |
acute, serum, sickness-like, syndrome, |
acute, ST-elevation, myocardial, inferction, STEMI, |
| acute, subarachnoid, hemorrhage, |
acute, tubular, damage, |
acute, tubular, injury, |
| acute, tubular, necrosis, |
acute, tubular, necrosis, ATN, |
acute, tubulointerstitial, injury, |
| acute, tubulointerstitial, nephritis, |
acute, tubulointerstitial, nephritis, AIN, |
acute, tubulointerstitial, nephritis, TIN, |
| acute, upper, respiratory, tract, infections, |
acute, urinary, retentio, AUR, |
acute, venous, thromboembolism, VTE, |
| acute-/chronic, CsA, nephropathy, |
acute-/chronic, dysfunction, |
acute-/chronic, hepatitis, C, |
| acute-/chronic, inflammation, |
acute-/chronic, kidney, disease, AKD/CKD, |
acute-/chronic, kidney, disease, CKD, |
| acute-/chronic, myeloid, leukemia, |
acute/chronic, potassium, handling, |
acute-/chronic, rejection, |
| acute-/chronic, tubular, injury, |
acute-/chronic, tubulo-interstitial, nephritis, |
acute-/chronic, tubulointerstitial, nephritis, TIN, |
| acute-mortality, |
acuty, kidney, injury, AKI, |
acyclovir, |
| acyl, ghrelin, |
acylovir, toxicity, |
ADA, deficiency, |
| adacolumn, filter, |
adalimumab, |
ADAM10, |
| ADAM10/ADAM17, |
ADAM-17, |
ADAMTS, 13, |
| ADAMTS, 13, deficiency, |
ADAMTS13, |
ADAMTS13, antigen, |
| ADAMTS13, gene, |
ADAMTS13, gene, mutations, |
ADAMTS13, inhibitory, antibody, |
| ADAMTS9, |
adaptive, immune, response, |
adaptive, immune, responses, |
| adaptive, immune, system, |
adaptive, immunity, |
adaptor, proteins, MyD88, |
| ADC, |
Addison’s, disease, |
additional, finger/-toe, |
| additive, therapy, |
add-on, treatment, |
adefovir, |
| adefovir, dipivoxil, ADV, |
adenine, phosphoribosyl-transferase, deficency, |
adenine, phosphoribosyl-transferase, deficiency, |
| adeno-associated, viral, (AAV), vector, |
adenoma, sebaceum/facial, angiomyofibromata, |
adenosine, |
| adenosine, 5’, triphosphate, ATP, |
adenosine, antagonists, |
adenosine, deaminase, (ADA), deficiency, |
| adenosine, deaminase, deficiency, ADA-SCID, |
adenovirus, |
adherens, junction, |
| adherens, junction, AJ, |
adherent, crystals, |
adhesion, |
| adhesion, molecule, |
adhesion, molecules, |
adhesion/proliferation/migration, |
| adhesive, capacity, |
ADHR/ARHR, |
adipocyte, |
| adipocyte, derived, protein, |
adipocyte, differentiation, |
adipocyte, fatty, acid-binding, protein, A-FABP, |
| adipocyte, progenitor, cells, |
adipocyte, synthesized, ApoE, |
adipocyte-derived, aldosterone-releasing, factors, ARFs, |
| adipocytes, |
adipocyte-secreted, peptide, |
adipocytokine, |
| adipocytokines, |
adipogenesis, |
adipokine, |
| adipokines, |
adiponectin, |
adiponectin, ADPN, |
| adiponectin, gene, ADIPOQ, |
adiponectin, gene, polymorphisms, |
adipose, tissue, |
| adipose, tissue, AT, |
adipose, tissue, function, |
adipose, tissue, loss, |
| adipose, tissue, macrophage, ATM, |
adipose, tissue-derived, mesenchymal, stem, cell, h-AD-MSC, |
adipose, tissue-derived, stromal, cells, ADSCs, |
| adipose-derived, stem, cells, |
adipose-tissue, derived, hormones, |
adiposity, |
| Adison’s, disease, |
AdiStem, |
adjunctive, regimens, |
| ADMA, |
administration, route, |
AdoHcy, deficiency, |
| adolescent, |
adolescent, cancers, |
adolescents, |
| adoloescents, |
adolscents, |
ADPKD, |
| ADPKD, families, |
ADPKD/ARPKD, |
ADP-ribosyl-cyclase, activity, ADPRCA, |
| ADRB2, |
adrenal, cortex, |
adrenal, glands, |
| adrenalectomy, |
adrenalitis, |
adrenergic, activity, |
| adrenergic, beta-1, ADRB1, receptor, |
adrenergic, receptor, blockers, |
adrenomedullin, |
| adrenomedullin, AM, |
adrenomedullins, |
adriamycin, model, |
| adriamycin, nephrosis, AN, |
adsorbent, therapy, |
adult, cell, lines, |
| adult, disease, |
adult, Henoch-Schönlein, purpura, HSP, |
adult, human, mesenchymal, stem, cells, |
| adult, life, |
adult, offsprings, |
adult, onset, |
| adult, pathologies, |
adult, patients, |
adult, recipients, |
| adult, stem, cells, |
adult, stem, cells, sources, |
adult, Still’s, disease, |
| adult, survivors, |
Adult, Treatment, Panel, III, ATP, III, |
Adult, Treatment, Panel, III, ATP-III, |
| adult, type, XLAS, mutations, |
adulthood, |
adult-onset, disease, states, |
| adult-onset, diseases, |
adults, |
adult-to-adult, living, donor, liver, transplantation, A-A, LDLT, |
| ADVANCE, |
advanced, age, |
advanced, ages, |
| advanced, CKD, |
advanced, diseases, |
advanced, donor, age, |
| advanced, glyaction, end, products, AGEs, |
advanced, glycation, |
advanced, glycation, end, product, AGE, |
| advanced, glycation, end, products, (AGE), |
advanced, glycation, end, products, AGE, |
advanced, glycation, end, products, AGEs, |
| advanced, glyca-tion, end, products, AGEs, |
advanced, glycation, endproducts, AGE, |
advanced, glycation, endproducts, AGEs, |
| advanced, glycation, end-products, AGEs, |
advanced, glycation, endproducts, RAGE, |
advanced, glycolysis, end-products, AGEs, |
| advanced, glycosylated, end, products, AGE, , |
advanced, lipoxidation, end-products, ALE, |
advanced, oxidation, protein, product, |
| advanced, oxidation, protein, products, , AOPP, |
advanced, oxidation, protein, products, AOPP, |
advanced, oxidation, protein, products, AOPPs, |
| advanced, renal, cell, |
adventitia/proximal, intima, |
adveres, events, AE, |
| adverse, cardiovascular, outcomes, |
adverse, drug, reactions, |
adverse, effects, |
| adverse, event, |
adverse, events, |
adverse, events, AE, |
| adverse, immunological, effect, of, r-HuEpo, |
adverse, metabolic, effects, |
adverse, outcomes, |
| adverse, reactions, |
adverse, renal, outcomes, |
adverse, vascular, events, |
| adynamic, renal, bone, disease, ARBD, |
aetiology, |
AF, levels, |
| affected, organs, |
affected, sib, pair, ASP, |
affected, sibling, pairs, ASP, |
| afferent, arteriolar, dilation, |
afferent, arteriole, vasoconstriction, |
afferent, nerve, fibers, |
| Affymetrix, oligonucleotide, microarrays, HG-U133A, |
African, Amercians, |
African, American, AA, |
| African, American, patients, |
African, American, population, |
African, Americans, |
| African, Americans, AA, |
African, ancestry, |
African, heritage, |
| African, infants, |
African-American, (AA), sibling, pairs, |
African-American, ethnicity, |
| agalsidase, |
agalsidase, alfa, |
agalsidase, alpha, |
| agalsidase, beta, |
AGE, |
age, /, female, gender, |
| AGE, receptor, RAGE, |
age, related, macular, degeneration, AMD, |
age/gender, |
| age-dependent, biochemical, alterations, |
age-dependent, phenomenon, |
AGE-induced, hypertrophy, |
| ageing, |
AGE-mediated, renal, tubulointerstitial, fibrosis, |
AGE-modification, |
| AGER, gene, |
AGER, gene, transcriptional, activity, |
AGE-RAGE, |
| AGE-RAGE, system, |
AGE-receptor-1, AGER1, |
age-related, disorders, |
| age-related, macular, degeneration, |
age-related, macular, degeneration, ADM, |
age-related, macular, degeneration, AMD, |
| AGEs, |
AGEs, tissue, levels, |
AGEs/RAGE, axis, |
| AGEs-bound, proteins, |
aggregated, IgA1, aIgA1, |
aging, |
| aging, kidney, |
aging, people, |
aging, population, |
| aging, process, |
aging-related, peptides, |
aging-related, renal, insufficiency, |
| agonism, of, acyl, ghrelin, |
agonistic, antibody, |
agouti-related, peptide, |
| agressive, adaptive, immune, response, |
AGT, haplotype, |
AGT, M235T, polymorphism, |
| AGTR1, |
AGTR2, |
AHI1, gene, |
| Ahmedabad, Tolerance, Induction, Protocol, ATIP, |
aHUS, |
aHUS-linked, fH, mutations, |
| AIAN, |
Aicardi-Goutieres, syndrome, AGS, |
AIDA, |
| AIDS, |
AIDS, manifestations, |
AIDS, patients, |
| aimal, models, |
AIP, peptide, |
air, pollution, |
| Aire, deficient, mTECs, |
Aire, expression, |
AIRE, gene, |
| AIRE1, gene, |
airway, fluid, clearence, |
airway, smooth, muscle, ASM, |
| AITD-asso-ciated, genes, |
AKI, |
AKI, classification, |
| AKI, Network, AKIN, |
AKI, severity, |
AKI, stages, |
| AKIN, classification, |
Akita, mice, |
AKL-0707, |
| Akt, |
Akt, kinase, |
Akt, phosphrylation, |
| Akt, signailng, proteins, |
Akt, signaling, pathway, |
Akt/PKB, |
| Akt/PKB, pathway, |
AKT-mediated, insulin, signaling, |
Akt-p38, interaction, |
| akute, kidney, injury, AKI, |
AL, amyloidosis, |
ALA, antiarrhythmic, properties, |
| ALA, consumption, |
ALA, conversion, |
ALA, health, benefits, |
| ALA, sources, |
Ala-allele, |
Alagille, syndrome, |
| Alaska, Natives, |
albumin, |
albumin, ahsg/fetuin, A, |
| albumin, ALB, |
albumin, creatinine, ratio, ACR, |
albumin, dialysis, |
| albumin, excretion, |
albumin, excretion, rate, AER, |
albumin, excretion, rates, |
| albumin, fragments, |
albumin, loss, |
albumin, permeabilty, Palb, |
| albumin, polymerization, |
albumin, replete, with, fatty, acids, |
albumin, to, creatinine, ratio, ACR, |
| albumin-/cholesterol, level, |
albumin/creatinine, ratio, ACR, |
albumin-creatinine, ratio, ACR, |
| albumin-creatinne, ratio, ACR, |
albumin-creatnine, ratio, ACR, |
albumin-to-creatine, ratio, ACR, |
| albumin-to-creatinine, ratio, ACR, |
albumin-to-creati-nine, ratios, ACR, |
albuminuria, |
| alcohol, |
alcohol, consumption, |
alcohol, inatke, |
| alcohol-induced, chronic, pancreatitis, |
aldose, reductase, (ALR2), gene, |
aldose, reductase, ALR2, |
| aldose, reductase, inhibitors, |
aldosterone, |
aldosterone, ALDO, |
| aldosterone, antagonists, |
aldosterone, antgonists, AA, |
aldosterone, blockade, |
| aldosterone, inhibitor, |
aldosterone, receptor, antagonism, |
aldosterone, receptor, antagonist, AA, |
| aldosterone, receptor, antagonists, |
aldosterone, synthase, C-344T, |
alefacept, |
| alemtuzumab, |
alemtuzumab, pretreatment, |
alendronate, |
| alertness, |
alfacalcidol, |
alfa-calcidol, |
| alfacalcidol, treatment, |
alfacalcitol, |
aliskiren, |
| alkaline, phosphatase, |
alkaline, phosphatase, ALP, |
alkaline, phosphatase, APH, |
| alkaline, phosphatase/barrier, functions, |
alkaline, phosphate, |
alkalinization, |
| alkylating, agents, |
all, cell, types, |
ALL, panel, |
| ALlambda/ALkappa, amyloid, |
all-cause, death, |
all-cause, mortality, |
| allele, frequencies, |
allele, frequency, |
allelic, architecture, |
| allelic, combinations, |
allelic, frequencies, |
allelic, heterogeneity, |
| allelic, model, |
allelic, mosaic, pheontype, |
allergen, |
| allergen-specific, IgE, |
allergic, |
allergic, disease, |
| allergic, diseases, |
allergic, patients, |
allergic, purpura, |
| allergy, |
alloantibodies, |
alloantigen, |
| allogeneic, HCT, |
allogeneic, organ, transplantation, |
allogeneic, sensitization, |
| allogeneic, stem, cell, transplantation, SCT, |
allogeneic, transplantation, |
allograft, biopsies, |
| allograft, biopsy, |
allograft, core, biopsies, |
allograft, dysfunction, |
| allograft, failure, |
allograft, histology, |
allograft, injury, |
| allograft, kidney, |
allograft, loss, |
allograft, nephropathy, |
| allograft, outcome, |
allograft, rejection, |
allograft, survival, |
| allograft, survival/-function, |
allograft, vascular, anastomosis, |
allograft, vascular, thrombosis, |
| allograft/autograft, type, |
allografted, kidney, |
allopecia, areata, |
| allopurinol, |
allopurinol, hypersensitivity, syndrome, |
alloreactive, antibodies, |
| allostery, |
ALOFT/AVOID/ALLAY, studies, |
alopecia, |
| alopecia, areata, |
ALOX5AP, |
alpha, (IV), chains, |
| alpha, adductin, G460W, |
alpha, klotho, gene, |
alpha, klotho, protein, |
| alpha, linolenic, acid, ALA, |
alpha, smoot, muscle, actin, alpha, SMA, |
alpha, thalassemia, |
| alpha, tocopherol, |
alpha/beta-blocker, |
alpha-1, antitrypsin, |
| alpha1, IV-/alpha1, V, collagens, |
alpha1-adrenergic, receptor, antagonist, |
alpha1-adrenergic, receptor, antagonists, |
| alpha1-antitrypsin, |
alpha1-microglobulin, |
alpha-1-microglobulin, |
| alpha1-microglobulin, alpha1-ug, |
alpha-1-microglobulin, AMG, |
alpha-2, adrenergic, receptor, agonists, |
| alpha2, I, collagen, COL1A2, |
alpha2,, 6-sialyltransferase, |
alpha2-adrenergic, receptor, agonists, |
| alpha2-macroglobulin, |
alpha3(IV), |
alpha3, (IV), collagen, |
| alpha3, integrin, |
alpha4(IV), |
alpha4-integrin, (VLA-4), monoclonal, antibody, |
| alpha5(IV), |
alpha5, chain, |
alpha7-NAChR, subtype, |
| alpha-actinin-4, |
alpha-actinin-4, mutant, |
alpha-dystroglycan, alpha-DG, |
| alpha-enolase, |
alpha-Fodrin, |
alpha-galactosidae, A, |
| alpha-galactosidase, |
alpha-galactosidase, A, |
alpha-galactosidase, A, defiency, |
| alpha-galactosidase, alpha-Gal, A, |
alpha-globin, genes, |
alpha-glucosidase, inhibitors, |
| alpha-IFN, monotherapy, |
alpha-klotho, mutation, |
alpha-LA, treatment, |
| alpha-l-iduronidase, deficiency, |
alpha-linolenic, acid, ALA, |
alpha-lipoic, acid, ALA, |
| alpha-lipoic, acid, alpha-LA, |
alpha-oxoaldehydes, |
alpha-SMA, |
| alpha-smooth, muscle, actin, |
alpha-smooth, muscle, actin, alphaSMA, |
alpha-smooth, muscle, actin, alpha-SMA, |
| alpha-smooth-muscle, actin, |
alpha-smooth-muscle, actin, alpha-SMA, |
alphavbeta3, receptor, |
| Alport, renal, disease, |
Alport, syndrome, |
Alport, syndrome, AS, |
| Alport, syndrome, ATS, |
Alport, syndrome,, Goodpasture, syndrome, |
Alport’s, disease, |
| Alport’s, syndrome, |
Alport’s, syndrome, AS, |
Alström, syndrome, |
| Alstrom, syndrome, |
altered, biological, pathways, |
altered, diurnal, blood, pressure, (BP), |
| altered, diurnal, blood, pressure, BP, |
altered, glycosylation, |
altered, IgA1, galactosylation, |
| altered, insulin-/podocyte, signaling, |
altered, magnesium, balance, |
altered, taste, sensation, |
| alternativ, pathway, |
alternative, and, lectin, pathways, |
alternative, C3, convertase, C3bBb, |
| alternative, complement, pathway, |
alternative, complement, pathway, AP, |
alternative, oxidase, AOX, |
| alternative, pathway, |
alternative, pathway, AP, |
alternative, therapies, |
| alternative, therapy, |
aluminium, |
alveolar, capillaritis, |
| alveolar, capillary, walls, |
alveolar, hemorrhage, |
alveolar, macrophages, |
| alveolar, stretch, |
Alzheimer, disease, |
Alzheimer, Disease, Assessment, Scale, ADAS-Cog, |
| Alzheimer’s, disease, |
Alzheimer’s, diseases, |
Alzheimer’s, syndrome, |
| AM, pathway, |
amantadine, |
ambient, protein, levels, |
| ambrisentan, |
ambulatory, blood, pressure, ABP, |
ambulatory, blood, pressure, measurements, ABPM, |
| ambulatory, blood, pressure, monitoring, ABPM, |
AMD, age-related, macular, degeneration, |
amenorrhea, |
| amenorrhoea, |
American, children, |
American, College, of, Rheumatology, ACR, |
| American, ethnicities, |
American, Indian, AI, |
American, Indians, |
| American, Society, of, Anesthesiologists, ASA, |
AMG487, |
amifostine, (Ethylol), |
| amine, oxidase, |
amines, |
amino, acid, residues, |
| amino, acid, sequence, |
amino, acid, substitutions, |
amino, acid, variation, |
| amino, acids, |
amino, acids, metabolism, |
aminoaciduria, |
| aminophyl-lyne, |
amino-terminal, pro-BNP, NT-proBNP, |
aminotrans-ferase, |
| amiodarone, |
amitriptyline, |
AML1-ETO, fusion, gene, |
| amlodipine, |
amlodipine/benazepril, |
amniocentesis, |
| amoxicillin, AMPC, |
AMP-activated, protein, kinase, AMPK, |
AMP-activated, protein, kinase, AMPK, , |
| amphetamine, |
amphetamines, |
amphotericin, |
| amphotericin, B, |
AMPK, activation, |
amplification, ratio, AMPR, |
| amprenavir, |
ampulla, |
amputation, |
| amputation-risk, |
amylin, |
amylodosis, |
| amyloid, A, |
amyloid, A, (AA), protein, |
amyloid, A, protein, AA, type, |
| amyloid, ß, Aß, |
amyloid, deposits, |
amyloid, fibrils, |
| amyloid, myocardial, infiltration, |
amyloid, nephropathy, |
amyloid, of, fibrinogen, Afib, |
| amyloid, of, transthyretin, ATTR, |
amyloid, P-component, |
amyloid, protein, typing, |
| amyloid, subtypes, |
amyloid, types, |
amyloid-ß-peptides, |
| amyloid-deposits, |
amyloidoses, |
amyloidosis, |
| amyloidosis, AA, |
amyolidosis, |
amyotrophic, lateral, sclerosis, |
| amyotropic, lateral, sclerosis, |
ANA, |
ANA, /dsDNA, |
| anabolic, hormones, |
anabolic, steroids, |
anabolism, |
| anaemia, |
anaemia, in, men, |
anakinra, |
| anal, atresia, |
analgesic, effect, |
analgesic, nephropathy, |
| analgesic, nephropathy, AN, |
analgesic-associated, nephropathy, AAN, |
analgesics, |
| analogs, |
analogues, |
anal-rectum-/urethral, atresia, syndrome, |
| anaphylactic, shock, |
anaphylatoxin, C5a, |
anaphylaxis, |
| anatomic, locations, |
anatomic-/functional, changes, |
ANCA, |
| ANCA, associated, small, vessel, vasculitis, ASVV, |
ANCA, associated, vasculitis, |
ANCA, associated, vasculitis, ANCA-V, |
| ANCA, associated, vasulitides, |
ANCA, MPO, renal, vasculitis, |
ANCA, patients, |
| ANCA, specificity, |
ANCA, subclasses, |
ANCA+, necrotizing, GN, |
| ANCA-activated, neutrophil, functions, |
ANCA-associated, disease, |
ANCA-associated, glomerulonephritis, |
| ANCA-associated, GN, |
ANCA-associated, necrotizing, and, crescentic, glomerulonephritis, NCGN, |
ANCA-associated, necrotizing, crescentic, glomerulonephritis, |
| ANCA-associated, pauci-immune, glomerulonephritis, |
ANCA-associated, small, vascultis, AASV, |
ANCA-associated, small, vessel, vasculitis, AASV, |
| ANCA-associated, small-vessel, vasculitis, |
ANCA-associated, small-vessel, vasculitis, AAV, |
ANCA-associated, systemic, vasculitides, AASVs, |
| ANCA-associated, systemic, vasculitis, AASV, |
ANCA-associated, vasculitides, AAVs, |
ANCA-associated, vasculitis, |
| ANCA-associated, vasculitis, AASV, |
ANCA-associated, vasculitis, AAV, |
ANCA-associated, vasculits, |
| ANCA-induced, crescentic, glomerulonephritis, NCGN, |
ANCA-negative, crGN, |
ANCA-negative, patients, |
| ANCA-positive, patients, |
ANCA-positive, pauci-immune, crescentic, glomerulonephritis, crGN, |
ANCA-positive, pauci-immune, glomerulonephritis, |
| ANCA-related, glomerulonephritis, |
ANCAs, |
ancestry-informative, markers, AIMs, |
| ancient, bacteria, |
ancient, conserved, domain, protein, ACDP, |
Anderson-Fabry, disease, |
| Anderson-Hynes, pyeloplasty, |
androgen, action, |
androgen, deficiency, |
| androgen, deprivation, therapy, ADT, |
androgen, index, |
androgen, level, |
| androgen, receptor, |
androgen, receptor, gene, |
androgen, supplementation, |
| androgens, |
andvanced, glycation, end, products, AGEs, |
andvanced, glycation, end-products, inhibitors, |
| anemia, |
anemia, correction, |
anemia, management, |
| anemia, of, chronic, disease, (ACD), |
anesthesiologist, |
aneurysm, |
| aneurysmal-infrarenal, aortic, diameter, |
aneurysms, |
anexins, III/VI, |
| anfibrotic, agents, |
Ang-(1-7), |
ANG-(1-7), therapy, |
| ANG-(1-7)-Mas, receptor, |
Ang, 1, antagonists, |
ANG, I, |
| ANG, II, |
Ang, II, receptors, |
Ang, II, reduction, |
| Ang, II, T1, receptor, A1166C, |
Ang, II, type, 1, receptor, (AT1), |
Ang, II, type, 2, receptor, |
| Ang, II, type, 2, receptor, (AT2), |
Ang, II-induced, changes, |
Ang, receptor/, Tie, 2, |
| Ang/Tie2, biology, |
Ang1/Ang2, |
Ang1/Tie2, signalling, |
| Angelman, (AS), syndromes, |
Angelman, , syndrome, |
Ang-II, |
| angina, pectoris, |
angio-dysplasia, |
angioedema, |
| angiogenesis, |
angiogenesis, inhibitor, drugs, |
angiogenesis-/tumor, cell, proliferation, inhibitor, |
| angiogenic, capcity, |
angiogenic, cytokines, |
angiogenic, factors, |
| angiogenic, function, |
angiogenic, mediators, |
angiogenic, pathways, |
| angiogenin, |
angiography, |
angio-graphy, |
| angiography, AG, |
angioimmunoblastic, T-cell, lymphoma, AITL, |
angiomyolipoma, |
| angiomyolipoma, AML, |
angiontensin-converting, enzyme, inhibitor, ACEI-/angiotensin, receptor, blocker, ARB-/prednisolone, PSL-treatment, |
angio-oedema/edema, AE, |
| angiopathies, |
angioplasty, |
Angioplasty, and, Stenting, for, Renal, Artery, Lesions, |
| angiopoietin, (Ang), biology, |
angiopoietin, family, Angs, 1-4, |
angiopoietin-tyrosine, kinase, |
| angiostatic, factors, |
angiostatin, |
angiotensin-(1-7), ANG-(1-7), |
| angiotensin, |
angiotensin, (Ang), II, formation, |
angiotensin, ANG, II, |
| angiotensin, AT, (1), receptor, |
angiotensin, AT1, receptor, |
angiotensin, AT1, receptor, blockade, |
| angiotensin, blockade, |
angiotensin, converting, enzyme, (ACE), inhibitors, |
angiotensin, converting, enzyme, ACE, |
| angiotensin, converting, enzyme, ACE2, |
angiotensin, converting, enzyme, ihibitor, ACEi, |
angiotensin-, converting, enzyme, inhbitor, ACEi, |
| angiotensin, converting, enzyme, inhibitor, ACEI, |
angiotensin, converting, enzyme, inhibitors, ACEIs, |
angiotensin, converting, enzyme, insertion/deletion, ACE, I/D, |
| angiotensin, I, |
angiotensin, I, Ang, I, |
angiotensin, I, converting, enzyme, insertion/deletion, ACE, I/D, |
| angiotensin, II, |
angiotensin, II, (AngII), production, |
angiotensin, II, Ang, II, |
| angiotensin, II, formation, |
angiotensin, II, generation, |
angiotensin, II, receptor, ARB, |
| angiotensin, II, receptor, blockade, ARB, |
angiotensin, II, receptor, blocker, ARB, |
angiotensin, II, receptor, blocker, ARBs, |
| angiotensin, II, receptor, blockers, ARB, |
angiotensin, II, receptor, blockers, ARBs, |
angiotensin, II, receptor, subtype, 2, ATR2, |
| angiotensin, II, receptor, type, I, AGTR1, |
angio-tensin, II, receptors, AT(1)R/AT(2)R, |
angiotensin, II, recpetor, blocker, ARB, |
| angiotensin, II, type, 1, (AT1), receptor, |
angiotensin, II, type, 1, receptor, (AT1R-AA), |
angiotensin, II, type, 1, receptor, AT, (1), R, |
| angiotensin, II, type, 1, receptor, AT1R, |
angiotensin, II, type, 1, receptor, ATR1, |
angiotensin, II, type, 1, receptor, blocker, |
| angiotensin, II, type, 1, receptor, blocker, ARB, |
angiotensin, II, type, 1, receptor, blockers, ARBs, |
angiotensin, II, type1, receptor, genes, |
| angiotensin, II-dependent, pathway, |
angiotensin, II-forming, enzyme, |
angiotensin, II-independent, pathway, |
| angiotensin, receptor, |
angiotensin, receptor, agonistic, autoantibodies, , AT1-AAs, |
angiotensin, receptor, AT1, |
| angiotensin, receptor, blockade, |
angiotensin, receptor, blocker, ARB, |
angiotensin, receptor, blockers, ARB, |
| angiotensin, receptor, blockers, ARBs, |
angiotensin, receptor, type-1, AGTR1-1166A>C, |
angiotensin, type, 1, AT, (1), receptor, |
| angiotensin, type, 2, receptor, AT2R, A1332G, |
angiotensin-converting, enzyme, |
angiotensin-converting, enzyme, (ACE), 2, |
| angiotensin-converting, enzyme, (ACE), inhibitors, ACEI, |
angiotensin-converting, enzyme, (ACE), types, 1/2, |
angiotensin-converting, enzyme, 2, ACE2, |
| angiotensin-converting, enzyme, ACE, |
angiotensin-converting, enzyme, inhbitors, ACEI, |
angiotensin-converting, enzyme, inhibitor, |
| angiotensin-converting, enzyme, inhibitor, ACEi, |
angiotensin-converting, enzyme, inhibitors, ACEI, |
angiotensin-converting, enzyme, inhibitors, ACEIs, |
| angiotensin-converting, enzymes, |
angiotensin-dependent, control, |
angiotensine, II, receptor, antagonists, ARA, |
| angiotensin-II, receptor, blocker, ARB, |
angiotensin-independent, intracellular, pathway, |
angiotensinogen, |
| angiotensinogen, (AGT), expression, |
angiotensinogen, AGT, |
angiotensinogen, AGT, M235T, |
| angiotensinogen, Ang, |
angiotensinogen, gene, |
angitensinogen, AGT, M235T, |
| Ang-Tie, system, |
anibiotics, |
anigogenesis, |
| animal, |
animal, foods, |
animal, model, |
| animal, models, |
Animal, Models, of, Diabetic, Complications, Consortium, AMDCC, |
animal, phyla, |
| animal, protein, |
animal, toxins, |
animals, |
| anion, exchange, resin, |
anion, exchanger, 1, (AE1,, Band, 3), |
anioxidants, |
| ankle-brachial, index, |
ankylosing, spondilits, ASP, |
ankylosing, spondylitis, |
| ankylosing, spondylitis, AS, |
annual, incidences, |
anorexia, |
| anorexia, /, sleep, disturbances, /, fatigue, |
anorexia, nervosa, |
anorexia-cachexia, |
| another, PHEX, mutation, |
anoxia, |
antagonist, R-954, |
| antenatal, micronutrient, supplementation, |
antenatal, ultrasonography, |
anterior, spinal, artery, |
| anthracyclines, |
anthropometric, parameters, |
anthropometric, status, |
| anti, factor, H, antibodies, |
anti, neutrophil, cytoplasmic, autoantibody, ANCA, |
anti-ADAMTS13, antibody, |
| anti-afctor, B, autoantibody, |
anti-AGE, property, |
anti-aging, factor, |
| anti-aldose, reductase, AR, |
anti-alpha4-integrin, mAb, |
anti-alpha-actinin/-nucleosome-/dsDNA, antibodies, |
| anti-angiogenesis, therapy, |
antiangiogenic, factors, |
anti-angiogenic, factors, |
| antiapoptotic, effect, |
antiapoptotic, effects, |
anti-apoptotic, gene, Bcl-XL, |
| anti-apoptotic, properties, |
anti-apoptotic-/-proliferative-/-inflammatory, drug, |
antiarrhythmic, agents, |
| anti-atherogenic, activity, |
antiatherogenic, effect, |
antiatheromatous, effects, |
| anti-atherosclerotic, drugs, |
antiatherosclerotic, effect, |
antibacterial, dosing, |
| anti-basement, membrane, antibodies, anti-GBM, antibodies, |
anti-B-cell, therapy, |
anti-beta, 2, glycoprotein, I, a-B2GPI, |
| anti-beta, 2, glycoprotein, I, ß2GPI, antibodies, |
anti-beta-cell, autoimmunity, |
antibiotic, |
| antibiotic, therapy, |
antibiotic-/antiviral, properties, |
antibiotics, |
| antibodies, |
antibodies, Abs, |
antibodies, against, annexin, A5, aAnA5, |
| antibodies, against, prothrombin, aPT, |
antibody, assay, |
antibody, atomistic, molecular, dynamics, simulations, |
| antibody, immunodeficiencies, |
antibody, mediated, rejection, |
antibody, mediated, rejection, AMR, |
| antibody, regions, |
antibody, removal, |
antibody, titer, |
| antibody, titers, |
antibody-induced, kidney, damage, |
antibody-mediated, defence, |
| antibody-mediated, disease, |
antibody-mediated, glomerulonephritis, |
antibody-mediated, rejection, |
| antibody-mediated, rejection, AMR, |
antibody-mediated, rejection, cytomegalovirus, infection, |
antibody-positive/-negative, patients, |
| antibody-producing, B, cells, |
antibody-secreting, cells, |
antibtics, |
| anti-C1q, antibodies, |
anti-C1q, antibodies, anti-C1, Abs, |
anti-C1q, antibodies, C1qAb, |
| anti-C1q, antibody, |
anti-C1q-/anti-dsDNA, antibodies, |
anti-CA, antibody, |
| anticachetic, effects, |
anticancer, agent, |
anticancer, agents, |
| anticancer, drugs, |
anticancer, efficacy, |
anticardiolipin, |
| anticardiolipin, aCL, |
anticardiolipin, aCL, antibodies, |
anticardiolipin, antibodies, ACA, |
| anticardiolipin, antibody, aCL, |
anti-cardiolipin/-beta2, glycoprotein, I, |
anti-CCP, Abs, |
| anti-CD20, |
anti-CD20, antibodies, |
anti-CD20, antibody, |
| anti-CD20, chimeric, monoclonal, antibody, |
anti-CD20, monoclonal, antibody, |
anti-CD25, monoclonal, antibodies, |
| anti-CD25, monoclonal, antibody, anti-CD25, MAb, |
Anti-CD3, |
anti-CD3, monoclonal, antibody, alpaCD3, moAb, |
| antichromatin, antibody, aCT, |
anticoagulant, effects, |
anticoagulants, |
| anticoagulation, |
anticonvulsants, |
anti-cPR3, antibodies, |
| anti-CTLA-4, |
anti-cyclic, citrullinated, peptides, anti-CCP, |
anti-dengue, IgG/IgM, antibody, |
| antidepressants, |
antidiabetic, therapy, |
antidiabetics, |
| antidiuretic, hormone, |
antidiuretic, hormone, AVP, |
anti-dsDNA, |
| anti-dsDNA, antibodies, |
anti-dsDNA, antibody, |
anti-dsDNA, ELISA, |
| anti-dsDNA, titers, |
antiendomysial, antibody, |
anti-endothelial, cell, , aECs, |
| anti-endothelial, cell, antibodies, AECA, |
antierythropoietin, antibodies, |
anti-fH, autoantibodies, |
| anti-fibrosis, agent, |
antifibrotic, action, |
antifibrotic, activity, |
| antifibrotic, agent, |
antifibrotic, drugs, |
antifibrotic, effects, |
| anti-fibrotic, potential, |
anti-fibrotic, properties, |
antifungal, prophylaxis, |
| antifungal, therapy, |
anti-GBM, antibodies, |
anti-GBM, antibody-induced, glomerulonephritis, |
| anti-GBM, disease, |
anti-GBM, glomerulonephritis, |
anti-GBM, model, |
| anti-GBM-associated, renal, disease, |
anti-GBM-associated, RPGN, |
anti-GBM-induced, experimental, nephritis, |
| anti-GBM-induced, glomerulonephritis, GN, |
antigen, antibody, reaction, |
antigen, presentation, |
| antigen, presenting, cells, |
antigen, presenting, cells, APCs, |
antigen, sensitization, |
| antigen, specific, adaptive, immune, response, |
antigen, specific, T, cells, |
antigen, specific, vaccination, |
| antigen, stimulation, |
antigen-driven, cell, differentiation, |
antigenic, peptides, |
| antigenic, targets, |
antigen-presenting, cell, |
antigen-presenting, cells, APC, |
| antigen-presenting, cells, APCs, |
antigens, |
antigen-specific, gene, therapy, |
| antigen-specific, GN, |
antigen-specificity, |
antigliadin, antibodies, AGA, |
| anti-glomerular, basement, membrane, (ant-GBM), glomerulonephritis, |
anti-glomerular, basement, membrane, (GBM), antibody, |
anti-glomerular, basement, membrane, (GBM), model, |
| anti-glomerular, basement, membrane, antibodies, anti-GBM, antibodies, |
anti-glomerular, basement, membrane, antibody, anti-GBM, |
anti-glomerular, basement, membrane, glomerulonephritis, anti-GBM, GN, |
| anti-glomerular, basement, membrane, models, |
anti-glomerular, basement, membrane, nephritis, |
anti-glomerular, basement, membrane-associated, glomerulonephritis, |
| anti-glutamate, receptor, epsilon2, antibodies, |
anti-HDL, antibodies, |
antihemagglutinin, (HI), antibody, |
| antihistamines, |
anti-HIV, drugs, |
anti-HIV/HCV/HBV, therapies, |
| antiHLA, antibodies, |
anti-HLA, antibodies, |
anti-human, E-cadherin, antibody, |
| anti-human, globulin, AHG, |
antihyperglycemic, agents, |
antihypertensive, agents, |
| antihypertensive, drug, classes, |
antihypertensive, drug, target, |
antihypertensive, drugs, |
| antihypertensive, effect, |
antihypertensive, management, |
antihypertensive, mediaction, |
| anti-hypertensive, medication, |
antihypertensive, therapy, |
antihypertensive, treatment, |
| antihypertensive-/non-immunosuppressive, agents, |
antihypertensives, |
anti-hypertrophic, effects, |
| antihyprtensive, mediactions, |
anti-IgA, antibody, |
anti-IL-6, receptor, antibodies, |
| anti-inflammatory, action, |
anti-inflammatory, activity, |
anti-inflammatory, agent, |
| anti-inflammatory, drug, |
anti-inflammatory, effect, |
anti-inflammatory, effects, |
| anti-inflammatory, genes, |
anti-inflammatory, mediators, |
anti-inflammatory, properties, |
| anti-inflammatory, therapies, |
anti-inflammatory-/immunomodulatory-/pleiotropic, effects, |
anti-inflammatory-/renoprotective, effect, |
| anti-integrin, monoclonal, antibody, |
anti-interleukin, 15, antibody, AMG714, |
anti-interleukin-2, receptor, antibody, |
| anti-La/SS-B, antibodies, |
anti-liver, kidney, microsomal, autoantibodies, |
anti-liver, kidney, microsome, type, 1, LKM1-/anti-liver, cytosol, autoantibody, LC1, |
| anti-liver-kidney, microsome-1, antibody, |
anti-liver-kidney-microsome, type, 1, autoantibodies, anti-LKM-1, |
anti-LPL, |
| antilymphocitic, drugs, |
anti-lymphocyte, antibodies, ALG/ATG, |
antilymphocyte, antibody, induction, |
| anti-lymphocyte, globulin, |
anti-malarial, agent, |
antimalarias, |
| anti-manganese, superoxide, dismutase, SOD2, |
antimicrobial, activty, |
antimicrobial, treatment, |
| antimitochondrial, antibody, |
anti-mitochondrial, autoantibody, AMA, |
anti-monocyte/macrophage, antibody, ED-1, |
| anti-MPO, antibodies, |
anti-MPO, GN, |
anti-MRSA, antibiotics, |
| antimycotic, or, antiviral, activity, |
antimyeloperoxidase, anti-MPO, |
antimyeloperoxidase, IgA, |
| anti-NC1, antibody, |
anti-neoplastic, effects, |
anti-neurtophilic, cytoplasmic, antibody, ANCA, |
| antineutrophil, antibody-associated, vasculitis, AAV, |
antineutrophil, cytoplasm, antibody, ANCA, |
anti-neutrophil, cytoplasm, antibody, ANCA, |
| antineutrophil, cytoplasmic, antibodies, ANCA, |
anti-neutrophil, cytoplasmic, antibodies, ANCA, |
antineutrophil, cytoplasmic, antibodies, ANCAs, |
| antineutrophil, cytoplasmic, antibodies, ANCAs, ANCA-asssociated, small, vessel, vasculitis, ASVV, |
antineutrophil, cytoplasmic, antibody, (ANCA), |
antineutrophil, cytoplasmic, antibody, ANCA, |
| anti-neutrophil, cytoplasmic, antibody, ANCA, |
antineut-rophil, cytoplasmic, antibody, ANCA, |
antineutrophil, cytoplasmic, antibody-associated, vasculitides, AAVs, |
| antineutrophil, cytoplasmic, autoantibodies, ANCA, |
antineutrophil, cytoplasmic, autoantibodies, ANCAs, |
anti-neutrophil, cytoplasmic, autoantibody, (ANCA)-associated, vasculitis, |
| antineutrophil, cytoplasmic, autoantibody, ANCA, |
anti-neutrophil, cytoplasmic, autoantibody, ANCA, |
anti-neutrophilic, cytoplasmic, (ANCA)-associated, glomerulonephritis, |
| anti-neutrophilic, cytoplasmic, antibodies, |
anti-nuclear, (ANA)-/anti-smooth, muscle, (SMA), antibodies, |
antinuclear, (ANA)/-dsDNA-/anticardiolipin, antibodies, |
| antinuclear, antibodies, ANA, |
anti-nuclear, antibody, |
antinuclear, antibody, ANA, |
| anti-nuclear, antibody, ANA, |
anti-nuclear, mitotic, apparatus, protein, (NUMA), antibody, |
antinuclear-/anti-Smith, antibodies, |
| antiophospholipid, antibodies, |
antioxidant, |
anti-oxidant, |
| antioxidant, activity, |
antioxidant, agent, |
antioxidant, capacity, |
| antioxidant, defence, pathways, , |
antioxidant, defense, |
antioxidant, defense, system, |
| antioxidant, drugs, |
antioxidant, enzymes, |
antioxidant, inadequacy, |
| antioxidant, pathway, |
antioxidant, potential, |
anti-oxidant, potential, |
| antioxidant, properties, |
antioxidant, response, element, ARE, |
antioxidant, systems, |
| anti-oxidant, therapy, |
antioxidant, thioredoxin, |
antioxidant, vitamin, E, |
| antioxidant-/-ischemic, effects, |
antioxidant-antiinflammatory, effects, |
antioxidants, |
| antioxidants, properties, |
antioxidative, effect, |
antioxidative, effects, |
| anti-oxidative, effects, |
antioxidative, properties, |
anti-oxidative/-apoptotic, effects, |
| antioxidative-/vasorelaxant, properties, |
antioxidized, LDL, antibodies, |
anti-oxLDL, |
| anti-p53, /, anti-Ki67, /, anti-caspase-3, /, anti-bcl2, /anti-cytokeratin, 22, antibodies, |
anti-pentraxin-/oxLDL-/ß2GPI-/heat-shock, protein, HSP, autoantibodies, |
antiphospholipid, (aPL), antibodies, |
| antiphospholipid, antibodies, |
anti-phospholipid, antibodies, |
antiphospholipid, antibodies, aPL, |
| anti-phospholipid, antibodies, aPL, |
antiphospholipid, antibody, syndrome, APS, |
antiphospholipid, syndrome, |
| antiphospholipid, syndrome, APS, |
antiphospholipid, syndrome, APS/Hughes, syndrome, |
antiphospholipid/anticardioipin, antibodies, |
| anti-PLA2R, autoantibodies, |
anti-PLA2R, IgG, subclass, |
antiplatelet, activity, |
| antiplatelet, agent, |
antiplatelet, agents, |
antiplatelet, drug, |
| antiplatelet, drugs, |
anti-platelet, therapy, |
antiplatelet, treatment, |
| anti-PR3, antibodies, |
antiproliferative, drugs, |
antiproliferative, effect, |
| anti-proliferative, effects, |
antiproteinase, 3, antineutrophil, cytoplasmic, antibodies, anti-PR3-ANCA, |
anti-proteinase, 3, IgA, |
| antiproteinuric, effect, |
antiproteinuric, effects, |
antiproteinuric, response, |
| anti-pS586, antibody, |
antipyretic, analgesics, |
antipyretic, effect, |
| anti-RAAS, intervention, |
antirejection, therapy, |
antirejection, treatment, |
| antiretroviral, agent, |
antiretroviral, drugs, |
antiretroviral, therapy, |
| antiretroviral, therapy, ART, |
antiretroviral, treatment, |
antiretrovirals, |
| anti-Ribosomal, P, |
anti-Ro/SS-A, antibodies, |
anti-self, immunological, responses, |
| anti-Sm, antibody, |
anti-smooth, muscle, antibody, |
anti-soluble, liver, antigen, SLA, |
| anti-SSA, antibody, |
anti-SSB, antibody, |
antistreptolysin-O, |
| anti-T, +, B, cell, antibodies, |
anti-T, +/-, B, cell, antibodies, |
anti-T-cell, globulin, (anti-thymocyte, globulin), ATG, |
| antithrombin, III, At, III, |
anti-thrombogenic, function, |
antithrombotic, agent, |
| antithrombotic, agents, |
antithrombotic, therapy, |
anti-Thy1.1-induced, glomerulonephritis, GN, |
| antithymocyte, globulin, |
antithymocyte, globulin, ATG, |
anti-thymocyte, globulin, ATG, |
| antithymocyte, serum, ATS, |
anti-thymoglobulin, ATG, |
antithyroglobulin, (Tg), Ab, |
| anti-thyroglobulin, antibody, |
antithyroperoxidase, TPO, Ab, |
anti-TNFalpha, |
| anti-TNFalpha, agents, |
antituberculous, agents, |
antitumor, activity, |
| anti-tumor, necrosis, factor, |
anti-tumor, necrosis, factor-alpha, therapy, |
anti-tumorigenic, function, |
| anti-vascular, endothelial, growth, factor, (VEGF), IgG, antibodies, |
anti-VEGF, antibodies, |
anti-VEGF, therapy, |
| antiviral, agents, |
antiviral, agents/antibiotics, |
antiviral, and, immunosuppressive, properties, |
| anti-viral, cytotoxic, T, cell, response, |
antiviral, defense, |
antiviral, drugs, |
| antiviral, IFN, response, |
anti-viral, miRNA, |
antiviral, prophylaxis, |
| antiviral, system, |
antiviral, therapy, |
antiviral, treatment, |
| antiviral-/immunosuppressive, effects, |
anti-VP-1, antibodies, |
anuric, renal, failure, |
| anuric, tubulointerstitial, nephritis, |
anxiety, |
aorta, |
| aorta, stiffness, |
aortic, aneurysm, |
aortic, calcification, |
| aortic, calcification, index, ACI, |
aortic, calcification, score, |
aortic, calfication, |
| aortic, dissection, |
aortic, pulse, pressure, |
aortic, pulse, wave, velocity, PWV, |
| aortic, PWV, |
aortic, regurgitation, |
aortic, stenosis, |
| aortic, stiffness, |
aortic, valve, |
aortic, valve, insufficency, |
| aortic-/coronary, calcification, |
aortography, |
aortorenal, bypass, |
| AP-1-like, element, |
APACHE, score, |
APACHE-HE, II, score, |
| apelin, |
apeptite, |
apical, megalin-receptors, |
| apical, membrane, |
apical-lateral, membrane, junction, |
aplastic, anemia, |
| aplastic, anemia, AA, |
aplastic, osteopathy, |
aPLs, |
| apnea-hypopnea, index, AHI, |
Apo, B, |
Apo, E, genotypes, |
| Apo, exon, 4, polymorphism, |
ApoA1, |
ApoA-II, |
| ApoB, |
APOBEC2, |
apocynin, |
| APOE |
APOE, |
ApoE, deficiency, |
| ApoE, epsilon2, alelle, |
ApoE, expression, |
ApoE, isoforms, |
| ApoE, mutations, |
ApoE, polymorphism, |
ApoE, recognizing, receptors, |
| ApoE3, phenotypes, |
ApoE4, phenotypes, |
Apo-I, mimetic, peptides, |
| apolipoprotein, (Apo), B, |
apolipoprotein, A/B, |
apolipoprotein, A1, |
| apolipoprotein, A-I, |
apolipoprotein, A-I, ApoA-I, |
apolipoprotein, A-IV, Apo, A-IV, |
| apolipoprotein, Apo, |
apolipoprotein, apoB, |
apolipoprotein, B, messenger, RNA-editing, enzyme, catalytic, polypeptides, 2, APOBEC2, |
| apolipoprotein, E, ApoE, |
apolipoprotein, E, genotype, |
apoplipoprotein, A, I, apoA-I, |
| apoptosis, |
apoptosis, signaling, pathways, |
apoptosis-inducing, factor, AIF, |
| apoptotic, cell, death, |
apoptotic, cells, |
apoptotic, cells, clearence, |
| apoptotic, renal, cells, |
apoptotic, signaling, cascades, |
apoptotic, signaling, mechanism, |
| Apo-rich, VLDL, |
apparent, diffusion, coefficients, ADC, |
appetite, |
| appetite, centres, |
appetite, homeostasis, |
appetite, loss, |
| appetite-regulating, centers, |
appoptosis, |
aprotinin, |
| APS, |
APS, classification, |
APS, classification, criteria, |
| APS, nephropathy, |
APSGN, |
AQP1-4, |
| aquaglyceroporins, |
aquaporin, |
aquaporin, 1/2, |
| aquaporin, 2, |
aquaporin, 2, mRNA, |
aquaporin, water, channels, |
| aquaporin-1, AGP1, |
aquaporin-2, |
aquaporin-2, water, channels, |
| aquaporins, AQPs, |
aquire, viral, infections, |
Arab, patients, |
| arachidonate, 12LO, gene, (ALOX12), |
ARB, |
ARBs, |
| archetype, clones, |
area, under, the, plasma, drug, concentration-time, curve, AUC, |
ARE-binding, protein, |
| ARF, |
ARF, exacerbations, |
arginase, |
| arginine, vasopressin, |
arginine, vasopressin, AVP/antidiuretic, hormone, ADH, |
arginine, vasopressin, receptor, 2, AVPR2, |
| Argonaute, (Ago), protein, |
arimoclomol, |
aristholochic, acid, AA, |
| Aristolochia, fangchi, |
Aristolochia, species, |
aristolochic, acid, |
| aristolochic, acid, (AA), |
Aristolochic, acid, (AA), nephropathy, |
aristolochic, acid, AA, |
| aristolochic, acid, I, AAI, |
aristolochic, acid, nephropathy, |
aristolochic, acid, nephropathy, AAN, |
| aristolochic, acid-induced, apoptosis, |
aristolochic, acids, |
aristolochic, acids, AA, |
| Arkadia, |
aromatic, amines, |
ARPKD, |
| array, comparative, genomic, hybridization, aCGH, |
array-based, proteomics, |
ArrayWiki, biocomputing, system, |
| arrhythimia, |
arrhythmia, |
arrhythmia, threshold, |
| arrhythmias, |
arrhythmic, phenotypes, |
arrhythmogenesis, |
| arsenic, |
arsenic, As, |
arstolochic, acid, AA, |
| ART, initiation, |
Artemis, gene, |
arterial, bypass, |
| arterial, calcification, |
arterial, compliance, |
arterial, disease, |
| arterial, hypertension, |
arterial, intima, |
arterial, intima, media, thickness, IMT, |
| arterial, pressure, |
arterial, sclerosis, |
arterial, stiffening, |
| arterial, stiffness, |
arterial, stiffness, Ast, |
arterial, subendothelial, space, |
| arterial, thickening/stiffening, |
arterial, thromboembolism, |
arterial, thrombosis, |
| arterial, underfilling, |
arterial, vasculature, |
arterial, vasodilatation, |
| arterial, wall, stiffness, |
arterial-/glo-merular, sclerosis, |
arterial-/venous, side, |
| arterial-/venous, thrombosis, |
arterial-ecchymotic, type, IV, Sack-Barabas, |
arterio-arteriolosclerotic, changes, |
| arteriolar, disease, |
arteriolar, hyalinization, |
arteriolar, hylinosis, |
| arteriolar, lumen, diameter, |
arterioles, |
arterioles/capillaries/venules, |
| arterioles-small, arterial, vessels, |
arteriolo-, sclerosis, |
arteriolopathy, |
| arteriolosclerosis, |
arterionephrosclerosis, |
arteriosclerosis, |
| arteriosclerotic, lesions, |
arteriotomy, closure, device, ACD, |
arterio-venosus, fistulae, |
| arterio-venous, difference, |
arteriovenous, fistula, |
arteriovenous, fistula, placement, |
| arteriovenous, malformations, |
artery, wall, |
arthralgia, |
| arthralgias, |
arthritis, |
arthritis/arthralgia, |
| arthrochalasia, |
arthropathy, |
arthrosis, |
| artificial, cells, |
artificial, heart, implantation, |
artificial, sweetener, |
| AS, WW, strains, |
AS605240, |
ASA, resistance, |
| asbestos, exposure, |
ascending, thick, limbs, |
ascending, thin, limbs, |
| ascites, |
ascorbic, acid, |
aseptic, meningitis, |
| Asian, ancestry, |
Asian, Indian, population, group, |
Asian, population, |
| Asian, populations, |
Asians, |
Asians, ethnicity, |
| Asia-Pacific, region, |
ASK1, gene, variants, |
aspartic, proteinase, |
| aspergillosis, IA, |
Aspergillus, flavus, |
Aspergillus, species, |
| aspiration, |
ASPIRE, HIGHER, |
ASPIRE, HIGHER, programme, |
| aspirin, |
aspirin, Asp, |
asporin, |
| association, of, myopathy, |
association, scan, |
AST-120, |
| AST-120/Kremezin, |
astaxanthin, |
asthma, |
| ASTRAL, |
astrocytes, |
asymetric, diemethylarginine, ADMA, |
| asymetric, dimethylarginine, ADMA, |
asymmetric, (N(G),N(G)), dimethylarginine, ADMA, |
asymmetric, dimethylarginine, |
| asymmetric, dimethylarginine, ADMA, |
asymmetric, dimet-hyl-arginine, ADMA, |
asymptomatic, |
| asymptomatic, clonal, B-cell, expansions, |
asymptomatic, coronary, artery, stenosis, CAS, |
asymptomatic, group, |
| asymptomatic, patients, |
asymptomatic, reactivation, |
asymptomatic, relatives, |
| asymptomatic, renal, cysts, |
asymptomatic, urinary, abnormalities, |
asynchronous, kidney, allograft, loss, |
| AT(1)R-/AT(2)R, protein/mRNA, |
AT(2), receptor, |
AT(2), receptor, antagonists, |
| AT, (1), receptor, antagonist, |
AT, macrophage, activation, |
AT, macrophages, ATMc, |
| AT1, , |
AT1, and, AT2, receptors, |
AT1, receptor, blockade, ARB, |
| AT1, receptor, blocker, ARB, |
AT1, receptor-/angiotensin, II, secretion, |
AT1-Aas, detection, |
| AT1R, blocker, |
AT2, receptor, |
AT2, receptor, signalling, |
| AT2, receptors, |
AT2R, GG, genotype, |
atacicept, |
| ataxia, |
Ataxia, teleangiectasia, AT, |
atazanavir, |
| AT-derived, stem, cell, therapy, |
atenolol, |
ATF2, mRNA, expression, |
| ATG16L1, autophagy-related, 16-like1, |
ATG-treatment, |
atheroembolization, |
| atherogenesis, |
atherogenic, apoC-III, rich, lipoproteins, |
atherogenic, dyslipidemia, |
| atherogenic, lipoprotein, |
atherogenic, lipoproteins, |
atherogenic, parameters, |
| atheroma, formation, |
atheromatous, renovascular, disease, ARVD, |
atherosclerosis, |
| athero-sclerosis, |
atheroscle-rosis, |
atherosclerosis, angiotensin, II, |
| atherosclerosis, AS, |
atherosclerosis, cancer, |
atherosclerosis, markers, |
| atherosclerosis, pathway, |
atherosclerosis, score, AS, |
atherosclerotic, complications, |
| atherosclerotic, disease, |
atherosclerotic, disease-related, genes, |
atherosclerotic, heart, disease, |
| atherosclerotic, lesions, |
atherosclerotic, medial, calcification, - |
atherosclerotic, renal, artery, stenosis, ARAS, |
| atherosclerotic, renovascular, disease, ARVD, |
atherosclerotic, vascular, disease, |
atherosclerotic-/arteriosclerotic-/cardiomyopathic, diseases, |
| atherosclrotic, lesions, |
atherothrombosis, |
atherothrombotic, complications, |
| atherothrombotic, events, |
athranilic, acid, |
AT-mutated, protein, ATM, |
| atomic, resolution, structures, |
atopic, dermatitis, |
atopic, dermatitis, , AD, |
| atopic, dermatitis, AD, |
atorvastatin, |
atorvastatin, therapy, |
| ATPase, activity, |
ATPase, cycle, |
ATPase, domain, |
| ATP-binding, casette, transporter, 1, |
ATP-binding, cassette, ABC, |
ATP-binding, cassette, transporter, A1, ABCA1, |
| ATP-dependent, ubiqutin-proteasome, system, UPS, |
ATP-ubiquitin-dependent, proteolytic, pathaways, |
ATR1, |
| ATR2, 1675, G>A, polymorphism, |
ATR2, 1675G>A, genotype, |
atrial, fibrillation, |
| atrial, fibrillation, AF, |
atrial, flutter, |
atrial, natriuretic, peptide, ANP, |
| atrophied, kidney, |
atrophy, |
ATS-, induced, mesangioproliferative, glomerulonephritis, ATS-GNGN, |
| attainment, of, ATP, III, |
attention, |
ATTR, type, |
| attractive, anabolic, agents, |
atubular, glomeruli, |
A-type, natriuretic, peptide, |
| atypical, ANCA, |
atypical, glycosy-lated, IgA-induced, PAF, |
atypical, haemolytic, uraemic, syndrome, aHUS, |
| atypical, hemolytic, uremic, syndrome, aHUS, |
atypical, hemolytic, uremic, syndrome, HUS, |
atypical, HUS, |
| atypical, HUS, aHUS, |
atypical, morphology, |
atypical, pauci-immune, glomerular, lesions, |
| atypical, phenotype, |
atypical, pneumonia, |
atypical, renal, necrotizing, glomerulonephritis, |
| atypical, renal, vasculitis, |
aucute, kidney, injury, AKI, |
audiogram, type, |
| auditory, hallucination, |
augmentaion, index, AI, |
augmentation, index, |
| augmentation, index, Aix, |
AU-rich, binding, factor, 1, AUF1, |
autism, |
| autism, spectrum, disorders, |
auto-Ag, genes, |
autoantibodies, |
| autoantibodies, Abs, |
autoantibodies, to, CFH, |
autoantibodies, to, neutrophil, cytoplasmic, antigens, ANCA, |
| auto-antibodies, to, the, CCL2, |
autoantibody, |
autoantibody, production, |
| autoanti-body-induced, nephritis, |
autoantigen, |
autoantigens, |
| auto-antigen-specific, T, cells, |
autoantigen-specific, tolerancia, |
autoantobodies, Abs, |
| autocrine, action, |
autocrine, effects, |
autocrine, fashion, |
| autocrine, mechanisms, , |
autocrine, role, |
autocrine/paracrine, fashion, |
| autocrine/paracrine, roles, |
autoimmune, AE, |
autoimmune, and, inflammatory, diseases, |
| autoimmune, cause, |
autoimmune, cholangitis, AIC, |
autoimmune, conditions, |
| autoimmune, cutaneous, vasculitis/-uveitis/-glomerulonephritis/-juvenile, chronic, arthritis, |
autoimmune, disease, |
autoimmune, diseases, |
| autoimmune, diseses, |
autoimmune, disorders, |
auto-immune, disorders, |
| autoimmune, encephalomyelitis, |
autoimmune, enteropathy, |
autoimmune, epithelitis, |
| autoimmune, extrahepatic, manifestations, |
autoimmune, glomerular, disease, |
autoimmune, glomerulonephritis, |
| autoimmune, hepatitis, |
autoimmune, hepatitis, AIH, |
autoimmune, hepatitis/-cholangitis, |
| autoimmune, hypothyroid, disease, |
autoimmune, mouse, model, |
autoimmune, nephritides, |
| autoimmune, neutropenia, |
autoimmune, pancreatitis, |
autoimmune, pancreatitis, AIP, |
| autoimmune, pattern, |
autoimmune, polyendocrinopathy, -, candidiasis, -, ectodermal, dystrophy, APECED, |
autoimmune, polyendocrinopathy-candidiasis, ectodermal, dysplasia, APECED, |
| autoimmune, polyglandular, syndrome, type, 1, |
autoimmune, polyglandular, syndrome, type, 1, APS1, |
autoimmune, polyglandular, syndrome, type, 1, APS-1, |
| autoimmune, process, |
autoimmune, prostatitis, |
autoimmune, response, |
| autoimmune, responses, |
autoimmune, symptoms, |
autoimmune, thrombocytopenia/-hemolytic, anemia, |
| autoimmune, thyroid, disease, |
autoimmune, thyroid, disease, AITD, |
autoimmune, thyroid, diseases, AITDs, |
| autoimmune, thyroiditis, |
autoimmune, thyroiditis/-myocarditis, |
autoimmune, vasculitis, |
| autoimmune-/, immune-mediated, diseases, |
autoimmune/immune, disorders, |
autoimmune-/inflammatory, diseases, |
| autoimmune-mediated, diseases, |
autoimmunity, |
autoimmunological, origin, |
| autoinflammatory, diseases, |
autoinflammatory, diseases/genetic, disorders, |
autoinflammatory, disorder, |
| autoinflammatory, disorders, |
autoinflammatory, syndrome, |
auto-inflammatory, syndromes, |
| autoinflammatory, syndromes, AS, |
autolgous, stem, cell, transplantation, |
autolgous, stem, cell, transplantation, ASCT, |
| autologous, bone, marrow, stem, cell, transfer, |
autologous, bone, marrow, transplantation, ABMT, |
autologous, dendritic, cells, |
| autologous, HCT, |
autolysosome, |
automated-gun, biopsy, devices, |
| autonomic, epilepsy, |
autonomic, function, |
autonomic, nervous, system, |
| autonomic, neuropathy, |
autonomic, regulation, |
autophagic, vacuoles, |
| autophagosomes, |
autophagy, |
autophagy, related, (Atg), genes, |
| autophagy, types, |
autopsy, |
autoreactive, B, cells, |
| autoreactive, helper, T, cells, |
autoreactive, Ig, receptors, |
autoreactive, lymphocytes, |
| autoreactive, T, cells, |
autosomal, |
autosomal, dominant, |
| autosomal, dominant, Alport, syndrome, |
autosomal, dominant, disease, |
autosomal, dominant, diseases, |
| autosomal, dominant, disorder, |
autosomal, dominant, granulomatous, disorder, |
autosomal, dominant, hypomagnesemia, and, hypocalciuria, |
| autosomal, dominant, hypomagnesemia, with, hypocalciuria, |
autosomal, dominant, insulin, resistance, |
autosomal, dominant, macrothrombocytopenias, |
| autosomal, dominant, PCLD, |
autosomal, dominant, PKD, ADPKD, |
autosomal, dominant, polycystic, kidney, disease, ADPKD, |
| autosomal, dominant, syndromes, |
autosomal, dominant, tubulointerstitial, nephropathies, |
autosomal, dominant/recessive, forms, |
| autosomal, dominant-/recessive, hypophosphatemic, rickets, |
autosomal, dominant-/recessive, polycystic, kidney, disease, ADPKD/ARPKD, |
autosomal, dominat, AS, ADAS, |
| autosomal, dominat, polycystic, kidney, disease, ADPKD, |
autosomal, genes, |
autosomal, inheritance, |
| autosomal, polycystic, kidney, disease, |
autosomal, recessive, |
autosomal, recessive, AS, ARAS, |
| autosomal, recessive, chronic, tubulointerstitial, disease, |
autosomal, recessive, chronic, tubulointerstitial, nephropathy, |
autosomal, recessive, disease, |
| autosomal, recessive, form, |
autosomal, recessive, hypomagnesemia, |
autosomal, recessive, inherited, disease, |
| autosomal, recessive, kidney, disease, |
autosomal, recessive, mendelian, disorder, |
autosomal, recessive, PKD, ARPKD, |
| autosomal, recessive, polycystic, kidney, disease, ARPKD, |
autosomal, recessive, polycystic, kidney, disease, ARPKD/PKD, |
autosomal, recessive, steroid-resistant, nephrotic, syndrome, NS, |
| autosomal, recessive-/dominant, inheritance, |
autosomal-dominant, disease, |
autosomal-dominant, hyper-IgE, syndrome, |
| autosomal-dominant, PKD, ADPKD, |
autosomal-dominant, polycystic, kidney, disease, ADPKD, |
autosomal-dominant, polycystic, liver, disease, PCLD, |
| autosomal-dominat, polycystic, kidney, disease, ADPKD, |
autosomal-recessive, renal, tubular, disorder, |
autosomal-recessive, susceptibility, |
| autosommal, recessive, disease, |
autotransplantation, |
autotrans-plantation, |
| avian, influenza, |
aviremia, |
AVOID, |
| AVOID, trial, |
avosentan, |
avosentan, SPP301, |
| AVP, affinity, |
AVPR2, gene, |
AVWS-WT, |
| axatinib, |
axitinib, |
axonal, damage, |
| axonal, regeneration, |
ß1-, /, alpha2-adrenergic, receptors, |
ß1/ß3, integrins, |
| ß2, integrins, (CD11/CD18), |
ß2-adrenergic, receptors, |
ß-2-glycoprotein, I, ß2GPI, |
| ß2-gycoprotein, I, ß2GPI, |
ß2-microglobulin, |
ß2-microglobulins, Aß2M, type, |
| ß-adrenergic, receptor, agonists, |
ß-adrenergic, signaling, pathway, |
ß-adrenoceptor, agonists/ß-agonists, |
| azathioprin, AZA, |
azathioprine, |
azathioprine, AZA, |
| ß-blockers, |
ß-blockers, BB, |
ß-blockes, |
| ß-cell, damage, |
ß-cell, lytic, virus, infection, |
ß-chain, of, HLA-DR, antigen, |
| azelnidipine, |
azotemia, |
ß-oxidation, |
| ß-thalassemia, |
